Search

Displaying results 6971 - 6980 of 10000 in total
  1. Drug

    Phoenix dactylifera pollen

    go.drugbank.com/drugs/DB10950
    Approved

    Phoenix dactylifera pollen is mainly used in allergenic testing.

  2. Drug

    Phalaris minor pollen

    go.drugbank.com/drugs/DB10963
    Approved

    Phalaris minor pollen is mainly used in allergenic testing.

  3. Drug

    Ulmus parvifolia pollen

    go.drugbank.com/drugs/DB11005
    Approved

    Ulmus parvifolia pollen is mainly used in allergenic testing.

  4. Drug

    Erteberel

    go.drugbank.com/drugs/DB07933
    Investigational

    Erteberel is an estrogen receptor beta agonist that has been used in trials studying the treatment of Benign Prostatic Hyperplasia.

  5. Drug

    Schinus terebinthifolia pollen

    go.drugbank.com/drugs/DB21762
    Approved

    Schinus terebinthifolia pollen is mainly used in allergenic testing.

  6. Drug

    Butyric Acid

    go.drugbank.com/drugs/DB03568
    Investigational

    A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.

    Synonyms: N-butyric acid, N-butanoic acid
  7. Drug

    Canis lupus familiaris skin

    go.drugbank.com/drugs/DB10409
    Approved

    Canis lupus familiaris skin allergenic extract is used in allergenic testing.

  8. Drug

    Cedar oil

    go.drugbank.com/drugs/DB10917
    Approved

    Cedar oil (Juniperus virginiana) allergenic extract is used in allergenic testing.

  9. Drug

    Efmarodocokin alfa

    go.drugbank.com/drugs/DB16398
    Investigational

    Efmarodocokin alfa is under investigation in clinical trial NCT04386616 (A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia).

    Synonyms: HUMAN INTERLEUKIN 22 (1-146), FUSED TO HUMAN IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 4 (CH1(97-98), H(S10>P(158)), CH2(N67>G(227)))-(147-377), DIMER (156-156':159-159')-BISDISULFIDE, PRODUCED IN CHO CELLS,
  10. Drug

    Pascolizumab

    go.drugbank.com/drugs/DB06560
    Investigational

    Pascolizumab (SB 240683) is a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.